MK-677 vs HGH: Secretagogue vs Direct Hormone
Here is how these two compounds compare — based on published research, not marketing claims.
MK-677 (Ibutamoren)
134
Indexed Studies
Human Trials
Evidence Level
Yes
Human Trials
Not Approved
FDA Status
HGH (Somatropin)
0
Indexed Studies
Preclinical
Evidence Level
None
Human Trials
Not Approved
FDA Status
PSI OVERVIEW
Here is the key difference between these compounds and what it means for the research.
MK-677 tells your pituitary gland to produce more growth hormone. HGH (human growth hormone) is the hormone itself, injected directly. One is indirect — your body does the work. The other is direct — you supply the finished product. This distinction has major implications for regulation, side effects, cost, and clinical evidence.
Key Differences
| Attribute | MK-677 (Ibutamoren) | HGH (Somatropin) |
|---|---|---|
| Evidence Level | Human Trials | FDA Approved |
| Category | Ghrelin Mimetic | Recombinant Growth Hormone |
| Human Data | Multiple human studies including 2-year elderly trial. PSI rates L3. | Extensive. FDA-approved for multiple indications. Decades of clinical data. |
| Safety Profile | Increases appetite. May elevate blood glucose and insulin. Water retention. Not FDA-approved. | Well-characterized. Side effects include joint pain, edema, carpal tunnel syndrome, insulin resistance. Requires medical monitoring. Misuse risks include acromegaly symptoms. |
| Key Limitations | Metabolic side effects. Appetite increase. Not direct GH replacement. | Expensive. Requires prescription and monitoring. Bypasses natural feedback loops. Potential for misuse. |
Mechanism Comparison
HOW THEY WORK
These compounds work through different biological pathways. Here is how each one operates at the cellular level.
MK-677 (Ibutamoren)
Oral compound that activates ghrelin receptors, stimulating your pituitary to release more GH naturally. Also triggers appetite through the same ghrelin pathway. Your body still controls the GH production process.
HGH (Somatropin)
Identical to human-produced growth hormone. Injected subcutaneously, it directly elevates GH levels regardless of pituitary function. Bypasses the body's regulatory mechanisms.
MK-677 stimulates — it tells your pituitary to make more GH. Your body still regulates the amount produced through natural feedback. HGH replaces — it provides the hormone directly, bypassing pituitary control. With MK-677, your body has the brake pedal. With HGH, you are controlling the gas directly.
Research Evidence
RESEARCH EVIDENCE
Between these compounds, researchers have published over 134 indexed studies. Here are the key findings.
HGH is L4 with FDA approval for multiple conditions and decades of clinical data. MK-677 is L3 with solid but more limited human studies. For proven GH replacement, HGH has incomparably more evidence. For GH optimization without prescription barriers, MK-677 is the most studied option.
For diagnosed GH deficiency requiring replacement, HGH is the standard of care.
For GH optimization without a deficiency diagnosis, MK-677 is more accessible.
For minimizing regulatory and prescription barriers, MK-677 is available without prescription in many contexts.
For precise GH dosing and medical monitoring, HGH provides more control.
Key Limitations
- •Not a fair comparison — HGH is an FDA-approved pharmaceutical, MK-677 is a research compound.
- •MK-677 cannot produce the same GH levels as exogenous HGH.
- •HGH requires prescription, medical monitoring, and significantly higher cost.
- •Long-term outcomes from MK-677 GH stimulation vs HGH replacement have not been compared.
PSI Verdict
SUPPORTED BY EVIDENCE
HGH effectively replaces growth hormone in deficient individuals, with FDA approval and decades of outcome data. MK-677 stimulates endogenous GH production through ghrelin receptor activation, with human data showing sustained GH and IGF-1 elevation.
NOT YET ESTABLISHED
Whether MK-677's indirect GH stimulation produces the same clinical outcomes as direct HGH replacement has not been demonstrated. MK-677 cannot match HGH for severe GH deficiency.
CONFIDENCE LEVEL
Very high for HGH as medical treatment. Moderate for MK-677 as an accessible GH optimization tool. These are different categories of intervention. Comparing them requires understanding what problem you are trying to solve.
Community Discussion
WHAT THE COMMUNITY IS SAYING
PSI monitors discussions across peptide research and biohacking communities. These are reported experiences, not clinical evidence.
MK-677 (Ibutamoren)
"MK-677 increased my growth hormone levels significantly"Supported by published data
"It made me hungry all the time and I gained fat"Supported by published data
"I use it for better sleep and recovery"Plausible but unproven
Safety Comparison
SAFETY PROFILE
What is currently known about the safety of each compound based on available research.
MK-677 (Ibutamoren)
Increases appetite. May elevate blood glucose and insulin. Water retention. Not FDA-approved.
HGH (Somatropin)
Well-characterized. Side effects include joint pain, edema, carpal tunnel syndrome, insulin resistance. Requires medical monitoring. Misuse risks include acromegaly symptoms.
HGH has more extensive safety data but also more serious potential side effects with improper use. MK-677 has metabolic concerns (glucose, appetite) but lower acute risk. HGH at supraphysiologic doses can cause acromegaly symptoms. MK-677 cannot push GH levels as high because your pituitary has natural limits.
WHAT THE RESEARCH SUGGESTS
HGH is the proven medical treatment. MK-677 is the accessible research alternative. They serve overlapping but different populations. HGH for diagnosed deficiency. MK-677 for optimization without prescription access.
Frequently Asked Questions
Explore Each Compound
For the full evidence profile, PSI Verdict, and indexed research data, visit each compound's dedicated page.
Looking for a physician experienced with peptide therapy?
Every physician in the PSI directory is individually verified for active licensure, board certification, and clinical peptide experience.
Browse the PSI Physician Directory →Explore Individual Research Pages
Related PSI Resources
Medical Disclaimer
This content is for educational and informational purposes only and does not constitute medical advice. The information presented reflects published research as indexed by PSI and should not be used to make treatment decisions. Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment.